AI software may help spot early signs of oesophageal cancer
Software in use at an NHS trust could prove a breakthrough in diagnosing one of the deadliest forms of cancerOne of the NHS ’s leading hospital trusts has begun using artificial intelligence to help detect cancer in the gullet, whichkills 8,000 Britons a year. It is hoped the technology will increase the number of cases of cancer in the oesophagus that doctors spot.Oesophageal cancer is one of the deadliest forms of cancer. It is hard to detect, particularly in its early stages, and many people who get it die soon after their diagnosis. Fewer than one in five of those diagnosed are still alive five years later.Contin...
Source: Guardian Unlimited Science - July 1, 2021 Category: Science Authors: Denis Campbell Health policy editor Tags: Cancer NHS Artificial intelligence (AI) Cancer research Medical research Health Science Society Technology UK news Source Type: news

Blood test for personalized cancer treatment
(Flinders University) A blood test to help guide the treatment of esophageal, stomach and bowel cancers will be evaluated in a new Flinders University trial set to get underway. The trial is thanks to a federal government grant of almost $2 million announced yesterday, with Flinders University awarded funding for three projects, totaling $5.8 million. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 1, 2021 Category: Cancer & Oncology Source Type: news

‘Sponge on a string’ test will help pinpoint gullet cancer
UK trials begin for test that detects risk of oesophageal diseaseTrials of a new weapon in the battle against cancer are to be launched across Britain next month. The cytosponge – a sponge on a string – is to be used to pinpoint individuals at risk of developing oesophageal cancer.The aim is to tackle one of Britain ’s most pernicious illnesses. Oesophageal cancer is often diagnosed late in its development when it is difficult to treat. It is the sixth most common cause of cancer deaths in the UK with only 15% of patients surviving five years after diagnosis and is more common in older people.Continue rea...
Source: Guardian Unlimited Science - June 27, 2021 Category: Science Authors: Robin McKie Tags: Cancer research Medical research Science UK news Source Type: news

Investigating a better treatment sequence for esophageal cancer
(University of Colorado Anschutz Medical Campus) University of Colorado Cancer Center member Martin McCarter, MD, is investigating whether a new treatment sequence will result in better outcome for patients with esophageal cancer. As they await the results of a group of clinical trials, McCarter and other CU researchers looked at data from the National Cancer Database to identify other patients who have undergone the new sequence, and what the outcomes for those patients were. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 22, 2021 Category: Cancer & Oncology Source Type: news

Running in the blood: Blood lipids are linked to cancer, but depending on family history
(Cactus Communications) Several studies have associated blood lipids with different types of cancer like that of the food pipe or 'esophagus,' but much remains to be understood, to apply this knowledge clinically. A group of Chinese scientists has successfully advanced this line of research, by identifying the role of family history in modifying the association between blood lipids and risk of developing esophageal malignant lesions, according to a new study published in Chinese Medical Journal. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 21, 2021 Category: Cancer & Oncology Source Type: news

Esophageal Cancer Responsive to Immune Cell Therapy + Nivolumab Esophageal Cancer Responsive to Immune Cell Therapy + Nivolumab
This report suggests that a combination of adoptive immune cell therapy and an immune checkpoint inhibitor might be a possible treatment strategy for advanced esophageal cancer.Journal of Medical Case Reports (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 17, 2021 Category: Consumer Health News Tags: Family Medicine/Primary Care Journal Article Source Type: news

FDA approves nivolumab in combination with chemotherapy for metastatic gastric cancer and esophageal adenocarcinoma
Hematology / Oncology (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - June 10, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Immunotherapy Likely New Standard in Advanced Esophageal Cancer Immunotherapy Likely New Standard in Advanced Esophageal Cancer
Nivolumab with chemotherapy or nivolumab with ipilimumab improved overall survival as compared with standard chemotherapy in advanced ESCC.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - June 3, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

FDA OKs Nivolumab After Surgery for Esophageal or GEJ Cancer FDA OKs Nivolumab After Surgery for Esophageal or GEJ Cancer
The adjuvant use of nivolumab has been described as practice-changing in patients with resected esophageal or gastroesophageal junction cancer who have received chemoradiotherapy before surgery.FDA Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 20, 2021 Category: Consumer Health News Tags: Hematology-Oncology News Alert Source Type: news

FDA approves nivolumab for resected esophageal or GEJ cancer
Hematology / Oncology News Burst (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - May 20, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news

As MRI strength increases, so do concerns about magnet safety
As the push toward stronger and faster MRI scanners continues, so does concer...Read more on AuntMinnie.comRelated Reading: Tips and tricks for finding lithium batteries in the esophagus on MRI Bedside point-of-care MRI appears convenient and accurate AI, radiomics can predict cancer in lesions found on breast MRI Ensuring patient privacy is key in MRI research projects 7T MRI shows promise for sports imaging of injured athletes (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - May 20, 2021 Category: Radiology Source Type: news

U.S. FDA Approves Opdivo (nivolumab) as Adjuvant Treatment of Completely Resected Esophageal or Gastroesophageal Junction Cancer in Patients who have Received Neoadjuvant Chemoradiotherapy
PRINCETON, N.J.--(BUSINESS WIRE) May 20, 2021 -- Bristol Myers Squibb (NYSE: BMY) today announced that the U.S. Food and Drug Administration (FDA) has approved Opdivo® (nivolumab, injection for intravenous use) for the adjuvant treatment of... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - May 20, 2021 Category: Drugs & Pharmacology Source Type: news

FDA Approves Opdivo (nivolumab) as Adjuvant Treatment of Completely Resected Esophageal or Gastroesophageal Junction Cancer in Patients who have Received Neoadjuvant Chemoradiotherapy
PRINCETON, N.J.--(BUSINESS WIRE) May 20, 2021 -- Bristol Myers Squibb (NYSE: BMY) today announced that the U.S. Food and Drug Administration (FDA) has approved Opdivo® (nivolumab, injection for intravenous use) for the adjuvant treatment of... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - May 20, 2021 Category: Drugs & Pharmacology Source Type: news

How Long Do You Live After Being Diagnosed With Esophageal Cancer?
Title: How Long Do You Live After Being Diagnosed With Esophageal Cancer?Category: Diseases and ConditionsCreated: 5/14/2021 12:00:00 AMLast Editorial Review: 5/14/2021 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - May 14, 2021 Category: Cancer & Oncology Source Type: news

Esophageal Cancer: Preop Chemoradiotherapy Benefit for 10 Years Esophageal Cancer: Preop Chemoradiotherapy Benefit for 10 Years
Among patients with locally advanced resectable esophageal or junctional cancer, the overall survival benefit conferred by preoperative chemoradiotherapy persists for at least 10 years.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 13, 2021 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Michael Atkinson obituary
My mentor and friend Michael Atkinson, who has died aged 95, was for many years professor of gastroenterology at the University of Nottingham, where one of his most important contributions was the development of the Atkinson tube, which helps people with oesophageal cancer to swallow.Born in Rawdon, just outside Leeds, to Herbert, a plumbers ’ merchant, and his wife, Janet (nee Palliser), a postmistress, Michael went to Aireborough grammar school in West Yorkshire, then University College London for his medical education during the second world war.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - May 13, 2021 Category: Science Authors: John Bennett Tags: Medical research Medicine Cancer research Hospitals Health NHS Leeds University of Nottingham Source Type: news

Esophageal cancers resurrect ancient retroviruses hidden in our genome
(Columbia University Irving Medical Center) Scientists have found that many esophageal cancers turn on ancient viral DNA embedded in our genome, a finding that could lead to improvements in immunotherapy. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 10, 2021 Category: International Medicine & Public Health Source Type: news

Increased use of minimally invasive non-endoscopic tests for Barrett's esophagus screening
(American College of Physicians) The authors of a new commentary from Mayo Clinic suggest that more extensive use of minimally invasive non-endoscopic tests for Barrett's esophagus (BE) screening could impact early detection and prevention of esophageal adenocarcinoma (EAC), a particularly deadly form of cancer. This is important because BE, the only known precursor to esophageal cancer, is often asymptomatic. Their commentary is published in Annals of Internal Medicine. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - May 3, 2021 Category: Infectious Diseases Source Type: news

What Are the Stages of Esophageal Cancer?
Title: What Are the Stages of Esophageal Cancer?Category: Diseases and ConditionsCreated: 4/30/2021 12:00:00 AMLast Editorial Review: 4/30/2021 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - April 30, 2021 Category: Cancer & Oncology Source Type: news

Humana partially reverses PET/CT policy
Humana will begin covering PET/CT imaging for gastric and esophageal oncologi...Read more on AuntMinnie.comRelated Reading: FDG-PET/CT may increase survival in SCC patients FDG-PET/CT effective for staging in new breast cancer SNMMI provides update on COVID-19 vaccine and PET/CT PET/CT shows link between stress and fatal heart condition Nuclear medicine groups oppose Humana PET/CT policy (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 27, 2021 Category: Radiology Source Type: news

Sculpting radiation beam spares lung cancer patients from severe, disabling complication
(Massachusetts General Hospital) The use of a novel esophagus-sparing technique reduces the rate of severe inflammation of the esophagus in patients with localized lung cancer receiving high-dose radiation and concurrent chemotherapy. Severe esophagitis was reduced despite tumors located within 1 centimeter of the esophagus, with no increased risk in local tumor recurrence. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 22, 2021 Category: Cancer & Oncology Source Type: news

Esophage cancer: Discovery of the mechanisms involved
(Universit é libre de Bruxelles) Publication in Cell Stem Cell: Researchers at the Universit é libre de Bruxelles, ULB uncover a new mechanism involved in the development of metaplasia in the oesophagus. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 21, 2021 Category: International Medicine & Public Health Source Type: news

Opdivo Plus Chemotherapy Approved for Treatment of Gastric Cancer
TUESDAY, April 20, 2021 -- Opdivo (nivolumab) is now approved for the treatment of advanced or metastatic gastric cancer, gastroesophageal junction cancer, and esophageal adenocarcinoma, the U.S. Food and Drug Administration announced Friday. The... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 20, 2021 Category: Pharmaceuticals Source Type: news

How Curable Is Cancer of the Esophagus?
Title: How Curable Is Cancer of the Esophagus?Category: Diseases and ConditionsCreated: 4/19/2021 12:00:00 AMLast Editorial Review: 4/19/2021 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - April 19, 2021 Category: Cancer & Oncology Source Type: news

FDA Approves Opdivo (nivolumab) in Combination with Chemotherapy for Patients with Advanced or Metastatic Gastric Cancer, Gastroesophageal Junction Cancer, and Esophageal Adenocarcinoma Regardless of PD-L1 Expression Status
PRINCETON, N.J.--(BUSINESS WIRE)-- April 16, 2021 Opdivo is the first and only immunotherapy in combination with chemotherapy to deliver superior overall survival versus chemotherapy alone in a trial of this patient population1 U.S. Food and... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - April 16, 2021 Category: Drugs & Pharmacology Source Type: news

FDA approves nivolumab in combination with chemotherapy for metastatic gastric cancer and esophageal adenocarcinoma
Hematology / Oncology (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 16, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Consumer Health: Treating esophageal cancer
April is Esophageal Cancer Awareness Month, which makes this a good time to learn more about treating esophageal cancer, the sixth most common cause of cancer deaths worldwide. Esophageal cancer is more common among men than women, and it can occur anywhere along the esophagus. Signs and symptoms of esophageal cancer include difficulty swallowing, unexplained [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - April 12, 2021 Category: Databases & Libraries Source Type: news

FDA D.I.S.C.O. Burst Edition: FDA approval of Keytruda (pembrolizumab) for patients with metastatic or locally advanced esophageal or gastroesophageal carcinoma
FDA D.I.S.C.O. Burst Edition: FDA approval of Keytruda (pembrolizumab) in combination with platinum and fluoropyrimidine-based chemotherapy for patients with metastatic or locally advanced esophageal or gastroesophageal carcinoma. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 9, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Esophageal Cancer: An Updated Review Esophageal Cancer: An Updated Review
The incidence of esophageal cancer is on the rise. Review its epidemiology, risk factors, diagnosis and management in this update.Southern Medical Journal (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 5, 2021 Category: Consumer Health News Tags: Family Medicine/Primary Care Journal Article Source Type: news

Mayo Clinic Q & amp;A podcast: Esophageal cancer is one of the deadliest cancers
Esophageal cancer occurs in the esophagus -- a long, hollow tube that runs from the throat to the stomach -- and can occur anywhere along the esophagus. Men are more likely to develop esophageal cancer than women. While treatable, esophageal cancer is rarely curable. "It's an uncommon cancer," says Dr. Shanda Blackmon, a Mayo Clinic general thoracic surgeon. [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - April 5, 2021 Category: Databases & Libraries Source Type: news

Adjuvant Nivolumab Beneficial in Esophageal, GE Junction Cancer
Disease - free survival significantly longer in patients with resected esophageal, gastroesophageal junction cancer (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - April 1, 2021 Category: Cancer & Oncology Tags: Gastroenterology, Oncology, Pharmacy, Journal, Source Type: news

Drug Could Be a ‘ Game - Changer ’ in Fighting Esophageal Cancers
(Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - April 1, 2021 Category: Cancer & Oncology Tags: Oncology, Pharmacy, News, Source Type: news

Adjuvant Nivolumab Beneficial in Esophageal, GE Junction Cancer
THURSDAY, April 1, 2021 -- Among patients with resected esophageal or gastroesophageal junction cancer who have received neoadjuvant chemoradiotherapy, disease-free survival is significantly longer with nivolumab adjuvant therapy versus placebo,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 1, 2021 Category: Pharmaceuticals Source Type: news

Drug Could Be a'Game-Changer' in Fighting Esophageal Cancers
THURSDAY, April 1, 2021 -- Patients who have surgery for esophageal cancer commonly see the disease return, but a drug that boosts the immune system may help delay or prevent that, a new trial has found. The drug, called Opdivo (nivolumab), doubled... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 1, 2021 Category: General Medicine Source Type: news

Drug Could Be a'Game-Changer' in Fighting Esophageal Cancers
Title: Drug Could Be a'Game-Changer'in Fighting Esophageal CancersCategory: Health NewsCreated: 4/1/2021 12:00:00 AMLast Editorial Review: 4/1/2021 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - April 1, 2021 Category: Cancer & Oncology Source Type: news

Discontinuing chemotherapy for oesophageal cancer cost effective?
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - April 1, 2021 Category: Drugs & Pharmacology Source Type: news

A ‘Game Changer’ for Patients With Esophageal Cancer
A drug that unleashes the immune system offers a rare glimmer of hope for those with a cancer that resists most treatments. (Source: NYT Health)
Source: NYT Health - March 31, 2021 Category: Consumer Health News Authors: Gina Kolata Tags: Clinical Trials Esophageal Cancer Drugs (Pharmaceuticals) Chemotherapy Radiation Alcoholic Beverages Bristol Myers Squibb Company New England Journal of Medicine East Asia United States Source Type: news

Procedures identify Barrett's esophagus patients at risk for cancer progression
(Johns Hopkins Medicine) A combination of esophageal brushing and extensive genetic sequencing of the sample collected can detect chromosome alterations in people with Barrett's Esophagus, identifying patients at risk for progressing to esophageal cancer, according to a new study by researchers at the Johns Hopkins Kimmel Cancer Center and Case Western Reserve University. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 29, 2021 Category: International Medicine & Public Health Source Type: news

FDA Approves Merck ’s Keytruda (pembrolizumab) Plus Platinum- and Fluoropyrimidine-Based Chemotherapy for Treatment of Certain Patients With Locally Advanced or Metastatic Esophageal or Gastroesophageal Junction (GEJ) Carcinoma
KENILWORTH, N.J.--(BUSINESS WIRE) March 23, 2021 -- Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved Keytruda, Merck’s anti-PD-1 therapy, for... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - March 23, 2021 Category: Drugs & Pharmacology Source Type: news

Electronic 'nose' that detects chemicals in breath may help spot early signs of oesophageal tumour 
The breathalyser-type device uses sensors to identify patterns of compounds found in breath that are unique to Barrett's oesophagus, a 'pre' condition to the cancer. (Source: the Mail online | Health)
Source: the Mail online | Health - March 23, 2021 Category: Consumer Health News Source Type: news

FDA approves pembrolizumab for esophageal or GEJ carcinoma
FDA approved pembrolizumab (Keytruda, Merck Sharp& Dohme Corp.) in combination with platinum and fluoropyrimidine-based chemotherapy for patients with metastatic or locally advanced esophageal or gastroesophageal carcinoma who are not candidates for surgical resection or definitive chemoradiation. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - March 22, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news

New Barrett's esophagus monitoring method could aid in easier and more precise prognoses
(Case Western Reserve University) Researchers find that a single esophageal brushing, combined with massively parallel sequencing, can identify Barrett's esophagus patients with disease progression to precancerous cells or carcinoma (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 22, 2021 Category: International Medicine & Public Health Source Type: news

Hospital becomes the first in the world to use a 'sponge on a string' to detect oesophageal cancer
University College London Hospital switched to the pioneering Cytosponge to assess patients after NHS bosses banned the use of endoscopies during the pandemic. (Source: the Mail online | Health)
Source: the Mail online | Health - March 17, 2021 Category: Consumer Health News Source Type: news

A new type of recyclable: Finding new uses for established drugs
(Tokyo Medical and Dental University) Using cell culture and mouse model approaches, researchers from Tokyo Medical and Dental University (TMDU) have found a novel drug combination that can inhibit tumor growth in oral and esophageal carcinomas. They also identified a potential biomarker that can help predict patient sensitivity to this treatment. These findings provide valuable knowledge for the fight against these deadly cancers and demonstrate a potential new use for drugs currently approved for other diseases. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 16, 2021 Category: Cancer & Oncology Source Type: news

Age Should Not Prevent Aggressive Esophageal Cancer Treatment Age Should Not Prevent Aggressive Esophageal Cancer Treatment
Neoadjuvant chemoradiation plus esophagectomy can be performed safely in well-selected older patients with locally advanced esophageal or esophagogastric junction cancer, according to a reviewMedscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 2, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Optimal Therapy for Esophageal Cancer Feasible in Fit Elderly
Those 70 years and older have similar postoperative complication scores and long - term survival (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - February 26, 2021 Category: Cancer & Oncology Tags: Gastroenterology, Oncology, Radiology, Surgery, Geriatrics, Journal, Source Type: news

Optimal Therapy for Esophageal Cancer Feasible in Fit Elderly
FRIDAY, Feb. 26, 2021 -- Patients 70 years and older with locally advanced esophageal or esophagogastric junction (EGJ) cancer should be considered for optimal, potentially curative therapy, including neoadjuvant chemoradiotherapy and surgical... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 26, 2021 Category: Pharmaceuticals Source Type: news

Chronic Heartburn Raises Odds for Cancers of Larynx, Esophagus
Title: Chronic Heartburn Raises Odds for Cancers of Larynx, EsophagusCategory: Health NewsCreated: 2/22/2021 12:00:00 AMLast Editorial Review: 2/23/2021 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - February 23, 2021 Category: Cancer & Oncology Source Type: news

Chronic Heartburn Raises Odds for Cancers of Larynx, Esophagus
(Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - February 23, 2021 Category: Cancer & Oncology Tags: Gastroenterology, Oncology, News, Source Type: news

Heartburn Raises Odds for Esophageal, Larynx Cancers
Researchers found that those with gastroesophageal reflux disease (GERD) had about twice the risk of developing cancers of the esophagus or larynx. (Source: WebMD Health)
Source: WebMD Health - February 22, 2021 Category: Consumer Health News Source Type: news